Targeted expression of HTLV-I envelope proteins in muscle by DNA immunization of mice

被引:11
作者
Armand, MA
Grange, MP
Paulin, D
Desgranges, C
机构
[1] INSERM, U271, Lyon, France
[2] Univ Paris 07, Paris, France
基金
澳大利亚研究理事会;
关键词
HTLV-I; DNA immunization; humoral response;
D O I
10.1016/S0264-410X(99)00565-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have compared two types of plasmids for DNA immunization against HTLV-I envelope glycoproteins. One type of plasmid contains the coding DNA of the complete envelope gene of HTLV-I under the control of the CMV promoter with (CMVenvLTR) or without (CMVenv) the tax/rex genes. The second type contains the coding DNA of the complete env gene of HTLV-I under the control of the human desmin muscle specific promoter (DesEnv). These plasmids were inoculated into mice and the humoral response was studied by flow cytometry, ELISA and neutralization assays. Inoculation of the DesEnv construct elicited a higher humoral response with better neutralization properties than the injection of CMVenvLTR or CMVenv plasmids. The choice of vectors will be important for the design of genetic HTLV-I vaccines. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2212 / 2222
页数:11
相关论文
共 43 条
[1]   Vaccination with HIV 1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit [J].
Barnett, SW ;
Rajasekar, S ;
Legg, H ;
Doe, B ;
Fuller, DH ;
Haynes, JR ;
Walker, CM ;
Steimer, KS .
VACCINE, 1997, 15 (08) :869-873
[2]  
BLATTNER WA, 1990, HUMAN RETROVIROLOGY : HTLV, P251
[3]   Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination [J].
Boyer, JD ;
Ugen, KE ;
Wang, B ;
Agadjanyan, M ;
Gilbert, L ;
Bagarazzi, ML ;
Chattergoon, M ;
Frost, P ;
Javadian, A ;
Williams, WV ;
Refaeli, Y ;
Ciccarelli, RB ;
McCallus, D ;
Coney, L ;
Weiner, DB .
NATURE MEDICINE, 1997, 3 (05) :526-532
[4]   PSEUDOTYPES OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE-1 AND TYPE-2 - NEUTRALIZATION BY PATIENTS SERA [J].
CLAPHAM, P ;
NAGY, K ;
WEISS, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (09) :2886-2889
[5]   DIRECT GENE-TRANSFER INTO SKELETAL-MUSCLE INVIVO - FACTORS AFFECTING EFFICIENCY OF TRANSFER AND STABILITY OF EXPRESSION [J].
DAVIS, HL ;
WHALEN, RG ;
DEMENEIX, BA .
HUMAN GENE THERAPY, 1993, 4 (02) :151-159
[6]   A novel human T-Leukemia virus type 1 cell-to-cell transmission assay permits definition of SU glycoprotein amino acids important for infectivity [J].
Delamarre, L ;
Rosenberg, AR ;
Pique, C ;
Pham, D ;
Dokhelar, MC .
JOURNAL OF VIROLOGY, 1997, 71 (01) :259-266
[7]   IDENTIFICATION OF NOVEL NEUTRALIZATION-INDUCING REGIONS OF THE HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-I ENVELOPE GLYCOPROTEINS WITH HUMAN HTLV-I-SEROPOSITIVE SERA [J].
DESGRANGES, C ;
SOUCHE, S ;
VERNANT, JC ;
SMADJA, D ;
VAHLNE, A ;
HORAL, P .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (02) :163-173
[8]  
DETHE G, 1993, AIDS RES HUM RETROV, V9, P351
[9]  
GESSAIN A, 1985, LANCET, V2, P407
[10]   DRUG-THERAPY - CANDIDATE AIDS VACCINES [J].
GRAHAM, BS ;
WRIGHT, PF .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (20) :1331-1339